Browse by Basel Contributors ID

2016

Dobrolecki, L. E. and Airhart, S. D. and Alferez, D. G. and Aparicio, S. and Behbod, F. and Bentires-Alj, M. and Brisken, C. and Bult, C. J. and Cai, S. and Clarke, R. B. and Dowst, H. and Ellis, M. J. and Gonzalez-Suarez, E. and Iggo, R. D. and Kabos, P. and Li, S. and Lindeman, G. J. and Marangoni, E. and McCoy, A. and Meric-Bernstam, F. and Piwnica-Worms, H. and Poupon, M. F. and Reis-Filho, J. and Sartorius, C. A. and Scabia, V. and Sflomos, G. and Tu, Y. and Vaillant, F. and Visvader, J. E. and Welm, A. and Wicha, M. S. and Lewis, M. T.. (2016) Patient-derived xenograft (PDX) models in basic and translational breast cancer research. Cancer and Metastasis Reviews, 35 (4). pp. 547-573.

Leroy, C. and Ramos, P. and Cornille, K. and Bonenfant, D. and Fritsch, C. and Voshol, H. and Bentires-Alj, M.. (2016) Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition. Breast Cancer Research, 18 (1). p. 41.

Lloyd-Lewis, B. and van de Moosdijk, A. A. and Bentires-Alj, M. and Clarke, R. B. and van Amerongen, R.. (2016) Complexity galore: 3D cultures, biomechanics and systems medicine at the eighth ENBDC workshop “Methods in Mammary Gland Development and Cancer”. Breast Cancer Research, 18 (1). p. 115.

Smirnova, T. and Bonapace, L. and MacDonald, G. and Kondo, S. and Wyckoff, J. and Ebersbach, H. and Fayard, B. and Doelemeyer, A. and Coissieux, M. M. and Heideman, M. R. and Bentires-Alj, M. and Hynes, N. E.. (2016) Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages. Oncotarget, 7 (50). pp. 82289-82304.

2015

Bentires-Alj, Mohamed and Rajan, Abinaya and van Harten, Wim and van Luenen, Henri G. A. M. and Kubicek, Stefan and Andersen, Jesper B. and Saarela, Janna and Cook, Simon J. and Van Minnebruggen, Geert and Roman-Roman, Sergio and Maurer, Cornelia and Erler, Janine T. and Bertero, Michela G.. (2015) Stimulating translational research: several European life science institutions put their heads together. Trends in Molecular Medicine, 21 (9). pp. 525-527.

Glukhova, Marina A. and Hynes, Nancy and Vivanco, Maria dM and van Amerongen, Renée and Clarke, Robert B. and Bentires-Alj, Mohamed. (2015) The seventh ENBDC workshop on methods in mammary gland development and cancer. Breast Cancer Research, 17. p. 119.

Koren, Shany and Bentires-Alj, Mohamed. (2015) Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy. Molecular Cell , 60 (4). pp. 537-546.

Koren, S. and Reavie, L. and Couto, J. P. and De Silva, D. and Stadler, M. B. and Roloff, T. and Britschgi, A. and Eichlisberger, T. and Kohler, H. and Aina, O. and Cardiff, R. D. and Bentires-Alj, M.. (2015) PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature, 525 (7567). pp. 114-118.

Leroy, C. and Shen, Q. and Strande, V. and Meyer, R. and McLaughlin, M. E. and Lezan, E. and Bentires-Alj, M. and Voshol, H. and Bonenfant, D. and Alex Gaither, L.. (2015) CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases. Oncogene, 34 (44). pp. 5593-5598.

Meier-Abt, F. and Bentires-Alj, M. and Rochlitz, C.. (2015) Breast Cancer Prevention: Lessons to be Learned from Mechanisms of Early Pregnancy–Mediated Breast Cancer Protection. Cancer Research, 75 (5). pp. 803-807.

Ramos, P. and Bentires-Alj, M.. (2015) Mechanism-based cancer therapy: resistance to therapy, therapy for resistance. Oncogene, 34 (28). pp. 3617-3626.

Sausgruber, N. and Coissieux, M. M. and Britschgi, A. and Wyckoff, J. and Aceto, N. and Leroy, C. and Stadler, M. B. and Voshol, H. and Bonenfant, D. and Bentires-Alj, M.. (2015) Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases. Oncogene, 34 (17). pp. 2272-2278.

2014

Bonapace, Laura and Coissieux, Maire-May and Wyckoff, Jeffrey and Mertz, Kirsten D. and Varga, Zsuzsanna and Junt, Tobias and Bentires-Alj, Mohamed. (2014) Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature, 515 (7525). pp. 130-133.

Duss, Stephan and Brinkhaus, Heike and Britschgi, Adrian and Cabuy, Erik and Frey, Daniel M. and Schaefer, Dirk J. and Bentires-Alj, Mohamed. (2014) Mesenchymal precursor cells maintain the differentiation and proliferation potentials of breast epithelial cells. Breast Cancer Research, 16 (3). R60.

Leroy, Cedric and Amante, Romain J. and Bentires-Alj, Mohamed. (2014) Anticipating mechanisms of resistance to PI3K inhibition in breast cancer: a challenge in the era of precision medicine. Biochemical Society Transactions, 42 (4). pp. 733-741.

MacDonald, Gwen and Nalvarte, Ivan and Smirnova, Tatiana and Vecchi, Manuela and Aceto, Nicola and Dolemeyer, Arno and Frei, Anna and Lienhard, Susanne and Wyckoff, Jeffrey and Hess, Daniel and Seebacher, Jan and Keusch, Jeremy J. and Gut, Heinz and Salaun, Daniele and Mazzarol, Giovanni and Disalvatore, Davide and Bentires-Alj, Mohamed and Di Fiore, Pier Paolo and Badache, Ali and Hynes, Nancy E.. (2014) Memo is a copper-dependent redox protein with an essential role in migration and metastasis. Science Signaling, 7 (329). ra56.

Meier-Abt, Fabienne and Bentires-Alj, Mohamed. (2014) How pregnancy at early age protects against breast cancer. Trends in Molecular Medicine, 20 (3). pp. 143-153.

Meier-Abt, Fabienne and Brinkhaus, Heike and Bentires-Alj, Mohamed. (2014) Early but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling. Breast Cancer Research, 16 (2). p. 402.

Meyer, D. S. and Aceto, N. and Sausgruber, N. and Brinkhaus, H. and Muller, U. and Pallen, C. J. and Bentires-Alj, M.. (2014) Tyrosine phosphatase PTPα contributes to HER2-evoked breast tumor initiation and maintenance. Oncogene, 33 (3). pp. 398-402.

Shostak, K. and Patrascu, F. and Göktuna, S. I. and Close, P. and Borgs, L. and Nguyen, L. and Olivier, F. and Rammal, A. and Brinkhaus, H. and Bentires-Alj, M. and Marine, J.-C. and Chariot, A.. (2014) MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation. Cell Death & Differentiation subscription, 21 (5). pp. 811-824.